| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, La Jolla, California 92093-0607
Address all correspondence and requests for reprints to: Dr. Elizabeth Barrett-Connor, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California 92093-0607.
A cross-sectional population-based study examined the association between endogenous sex hormones and depressed mood in community-dwelling older men. Participants included 856 men, ages 5089 yr, who attended a clinic visit between 198487. Total and bioavailable testosterone, total and bioavailable estradiol, and dihydrotestosterone levels were measured by radioimmunoassay in an endocrinology research laboratory. Depressed mood was assessed with the Beck Depression Inventory (BDI). Levels of bioavailable testosterone and bioavailable estradiol decreased with age, but total testosterone, dihydrotestosterone, and total estradiol did not. BDI scores increased with age. Low bioavailable testosterone levels and high BDI scores were associated with weight loss and lack of physical activity, but not with cigarette smoking or alcohol intake. By linear regression or quartile analysis the BDI score was significantly and inversely associated with bioavailable testosterone (both Ps = 0.007), independent of age, weight change, and physical activity; similar associations were seen for dihydrotestosterone (P = 0.048 and P = 0.09, respectively). Bioavailable testosterone levels were 17% lower for the 25 men with categorically defined depression than levels observed in all other men (P = 0.01). Neither total nor bioavailable estradiol was associated with depressed mood. These results suggest that testosterone treatment might improve depressed mood in older men who have low levels of bioavailable testosterone. A clinical trial is necessary to test this hypothesis.
This article has been cited by other articles:
![]() |
F. Laghi, N. Adiguzel, and M. J. Tobin Endocrinological derangements in COPD Eur. Respir. J., October 1, 2009; 34(4): 975 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Saini, L. Ostacoli, G. Gorzegno, R. L. Picci, L. Dogliotti, P. M. Furlan, and A. Berruti Risk of Depressive Events in Long-Term Surviving Patients Affected by Hormone-Related Cancer According to Time After Diagnosis J. Clin. Oncol., September 1, 2009; 27(25): e91 - e92. [Full Text] [PDF] |
||||
![]() |
M Ebinger, C Sievers, D Ivan, H. Schneider, and G. Stalla Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression? J Psychopharmacol, September 1, 2009; 23(7): 841 - 853. [Abstract] [PDF] |
||||
![]() |
F. R. Sattler, C. Castaneda-Sceppa, E. F. Binder, E. T. Schroeder, Y. Wang, S. Bhasin, M. Kawakubo, Y. Stewart, K. E. Yarasheski, J. Ulloor, et al. Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 1991 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Lapauw, S Goemaere, H Zmierczak, I Van Pottelbergh, A Mahmoud, Y Taes, D De Bacquer, S Vansteelandt, and J M Kaufman The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes Eur. J. Endocrinol., October 1, 2008; 159(4): 459 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lehtonen, R. Huupponen, J. Tuomilehto, S. Lavonius, S. Arve, H. Isoaho, I. Huhtaniemi, and R. Tilvis Serum testosterone but not leptin predicts mortality in elderly men Age Ageing, July 1, 2008; 37(4): 461 - 464. [Full Text] [PDF] |
||||
![]() |
A. Saini, M. Ardine, A. Berruti, and T. C. Long Major Depressive Disorder N. Engl. J. Med., April 24, 2008; 358(17): 1868 - 1869. [Full Text] [PDF] |
||||
![]() |
O. P. Almeida, B. B. Yeap, G. J. Hankey, K. Jamrozik, and L. Flicker Low Free Testosterone Concentration as a Potentially Treatable Cause of Depressive Symptoms in Older Men Arch Gen Psychiatry, March 1, 2008; 65(3): 283 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Giton, S. Urien, C. Born, J. Tichet, J. Guechot, J. Callebert, F. Bronsard, J. P. Raynaud, and J. Fiet Determination of Bioavailable Testosterone [Non Sex Hormone Binding Globulin (SHBG)-Bound Testosterone] in a Population of Healthy French Men: Influence of Androstenediol on Testosterone Binding to SHBG Clin. Chem., December 1, 2007; 53(12): 2160 - 2168. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Schroeder, C. Castaneda-Sceppa, Ying Wang, E. F. Binder, M. Kawakubo, Y. Stewart, T. Storer, R. Roubenoff, S. Bhasin, K. E. Yarasheski, et al. Hormonal regulators of muscle and metabolism in aging (HORMA): design and conduct of a complex, double masked multicenter trial Clinical Trials, October 1, 2007; 4(5): 560 - 571. [Abstract] [PDF] |
||||
![]() |
B. B Yeap, O. P Almeida, Z. Hyde, P. E Norman, S A P. Chubb, K. Jamrozik, and L. Flicker In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study Eur. J. Endocrinol., May 1, 2007; 156(5): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Okun, H. H. Fernandez, R. L. Rodriguez, J. Romrell, M. Suelter, S. Munson, E. D. Louis, T. Mulligan, P. S. Foster, B. V. Shenal, et al. Testosterone Therapy in Men With Parkinson Disease: Results of the TEST-PD Study. Arch Neurol, May 1, 2006; 63(5): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bloch, D. R. Rubinow, K. Berlin, K. R. Kevala, H.-Y. Kim, and P. J. Schmidt Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men. Arch Gen Psychiatry, April 1, 2006; 63(4): 450 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Giton, J. Fiet, J. Guechot, F. Ibrahim, F. Bronsard, D. Chopin, and J.-P. Raynaud Serum Bioavailable Testosterone: Assayed or Calculated? Clin. Chem., March 1, 2006; 52(3): 474 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Malkin, P. J. Pugh, J. N. West, E. J.R. van Beek, T. H. Jones, and K. S. Channer Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial Eur. Heart J., January 1, 2006; 27(1): 57 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Gray, A. B. Singh, L. J. Woodhouse, T. W. Storer, R. Casaburi, J. Dzekov, C. Dzekov, I. Sinha-Hikim, and S. Bhasin Dose-Dependent Effects of Testosterone on Sexual Function, Mood, and Visuospatial Cognition in Older Men J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3838 - 3846. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Bao, A. Hestiantoro, E. J. W. Van Someren, D. F. Swaab, and J.-N. Zhou Colocalization of corticotropin-releasing hormone and oestrogen receptor-{alpha} in the paraventricular nucleus of the hypothalamus in mood disorders Brain, June 1, 2005; 128(6): 1301 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Laghi, A. Antonescu-Turcu, E. Collins, J. Segal, D. E. Tobin, A. Jubran, and M. J. Tobin Hypogonadism in Men with Chronic Obstructive Pulmonary Disease: Prevalence and Quality of Life Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 728 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Orengo, L. Fullerton, and M. E. Kunik Safety and Efficacy of Testosterone Gel 1% Augmentation in Depressed Men With Partial Response to Antidepressant Therapy J Geriatr Psychiatry Neurol, March 1, 2005; 18(1): 20 - 24. [Abstract] [PDF] |
||||
![]() |
M. M. Shores, K. L. Sloan, A. M. Matsumoto, V. M. Moceri, B. Felker, and D. R. Kivlahan Increased Incidence of Diagnosed Depressive Illness in Hypogonadal Older Men Arch Gen Psychiatry, February 1, 2004; 61(2): 162 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Thompson, T. D. Shanafelt, and C. L. Loprinzi Andropause: Symptom Management for Prostate Cancer Patients Treated With Hormonal Ablation Oncologist, October 1, 2003; 8(5): 474 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Colao, C. Di Somma, S. Spiezia, M. Filippella, R. Pivonello, and G. Lombardi Effect of Growth Hormone (GH) and/or Testosterone Replacement on the Prostate in GH-Deficient Adult Patients J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 88 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Pope Jr., G. H. Cohane, G. Kanayama, A. J. Siegel, and J. I. Hudson Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial Am J Psychiatry, January 1, 2003; 160(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Ellison, R. G. Bribiescas, G. R. Bentley, B. C. Campbell, S. F. Lipson, C. Panter-Brick, and K. Hill Population variation in age-related decline in male salivary testosterone Hum. Reprod., December 1, 2002; 17(12): 3251 - 3253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Anderson, S. Faulkner, C. Cranor, J. Briley, F. Gevirtz, and S. Roberts Andropause: Knowledge and Perceptions Among the General Public and Health Care Professionals J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2002; 57(12): M793 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kunelius, O. Lukkarinen, M. L. Hannuksela, O. Itkonen, and J. S. Tapanainen The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1467 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Seidman, A. B. Araujo, S. P. Roose, D.P. Devanand, S. Xie, T. B. Cooper, and J. B. McKinlay Low Testosterone Levels in Elderly Men With Dysthymic Disorder Am J Psychiatry, March 1, 2002; 159(3): 456 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Feldman, C. Longcope, C. A. Derby, C. B. Johannes, A. B. Araujo, A. D. Coviello, W. J. Bremner, and J. B. McKinlay Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 589 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text] |
||||
![]() |
A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF] |
||||
![]() |
G. A. Laughlin and E. Barrett-Connor Sexual Dimorphism in the Influence of Advanced Aging on Adrenal Hormone Levels: The Rancho Bernardo Study J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3561 - 3568. [Abstract] [Full Text] |
||||
![]() |
H. C. Margolese The Male Menopause and Mood: Testosterone Decline and Depression in the Aging Male--Is There a Link? J Geriatr Psychiatry Neurol, July 1, 2000; 13(2): 93 - 101. [Abstract] [PDF] |
||||
![]() |
D. C Gould, R. Petty, and H. S Jacobs For and against: The male menopause---does it exist? • For • Against BMJ, March 25, 2000; 320(7238): 858 - 861. [Full Text] |
||||
![]() |
J. G. Rabkin, G. J. Wagner, and R. Rabkin A Double-blind, Placebo-Controlled Trial of Testosterone Therapy for HIV-Positive Men With Hypogonadal Symptoms Arch Gen Psychiatry, February 1, 2000; 57(2): 141 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Yates Testosterone in Psychiatry: Risks and Benefits Arch Gen Psychiatry, February 1, 2000; 57(2): 155 - 156. [Full Text] [PDF] |
||||
![]() |
S. Grinspoon, C. Corcoran, T. Stanley, A. Baaj, N. Basgoz, and A. Klibanski Effects of Hypogonadism and Testosterone Administration on Depression Indices in HIV-Infected Men J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 60 - 65. [Abstract] [Full Text] |
||||
![]() |
Depression and Low Bioavailable Testosterone Journal Watch Psychiatry, April 1, 1999; 1999(401): 22 - 22. [Full Text] |
||||
![]() |
Low Bioavailable Testosterone and Depression Journal Watch (General), February 23, 1999; 1999(223): 5 - 5. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |